Here is a copy of the talk I gave at the recent Marcusevans 13th Portfolio Management and Pipeline Optimization for Generics.
I cover:
- How to find and evaluate generic entry opportunities
- Litigation-free generic launch strategies
- How to leverage 505(b)(2) and branded generics
- How to learn from litigation
This talk is based on my work at DrugPatentWatch. Try a trial, or get the book, Make Better Decisions.
